Stay updated on COR388 for AD: Phase 2/3 Clinical Trial
Sign up to get notified when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.

Latest updates to the COR388 for AD: Phase 2/3 Clinical Trial page
- Check5 days agoChange DetectedA site-wide notice about NIH’s terminology transition appears, and the site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check33 days agoChange DetectedKey study documents such as the Statistical Analysis Plan and Study Protocol were removed from the Study Documents section along with related metadata. This change reduces public access to the trial's methodological details and documentation.SummaryDifference17%

- Check40 days agoChange DetectedThe page revision was updated from v3.6.6 to v3.7.0, indicating a new release of the page's software or documentation. This is a maintenance update and does not modify the study details or user-facing content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows Revision: v3.6.6 instead of v3.6.5. This reflects a minor version-label update and does not change the study content or user-facing functionality.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the page rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to COR388 for AD: Phase 2/3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COR388 for AD: Phase 2/3 Clinical Trial page.